GlassScriptPhysician profile
Robert W Feldtman
NPI 1851350227
$1,434.83
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $378 · 2021: $185 · 2022: $143.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $849.46 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $184.60 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $115.04 | 2019 | |
| Pfizer INC. | $55.58 | 2021 | |
| Veryan Medical Incorporated | $37.56 | 2022 | |
| Philips North America LLC | $35.59 | 2019 | |
| Angiodynamics, INC. | $33.88 | 2019-2022 | |
| Medtronic, INC. | $24.20 | 2021 | |
| Amarin Pharma, INC. | $23.05 | 2019 | |
| Kls-Martin L.P. | $20.31 | 2019 | |
| Boston Scientific Corporation | $15.26 | 2019 | |
| Bolton Medical INC | $15.18 | 2020 | |
| Tactile Systems Technology INC | $13.58 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.54 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Feldtman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.